Litcius/Paper detail

Apremilast as a potential treatment option for <scp>COVID</scp> ‐19: No symptoms of infection in a psoriatic patient

Olga Yu. Olisova, Ekaterina M. Anpilogova, Dariya A. Svistunova

2020Dermatologic Therapy20 citationsDOIOpen Access PDF

Abstract

Dermatologic TherapyVolume 33, Issue 4 e13668 Letter Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient Olga Yu Olisova, Olga Yu Olisova orcid.org/0000-0003-2482-1754 Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaSearch for more papers by this authorEkaterina M. Anpilogova, Corresponding Author Ekaterina M. Anpilogova [email protected] orcid.org/0000-0001-9478-5838 Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia Correspondence Ekaterina M. Anpilogova, Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. Email: [email protected]Search for more papers by this authorDariya A. Svistunova, Dariya A. Svistunova Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaSearch for more papers by this author Olga Yu Olisova, Olga Yu Olisova orcid.org/0000-0003-2482-1754 Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaSearch for more papers by this authorEkaterina M. Anpilogova, Corresponding Author Ekaterina M. Anpilogova [email protected] orcid.org/0000-0001-9478-5838 Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia Correspondence Ekaterina M. Anpilogova, Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. Email: [email protected]Search for more papers by this authorDariya A. Svistunova, Dariya A. Svistunova Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaSearch for more papers by this author First published: 24 May 2020 https://doi.org/10.1111/dth.13668Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume33, Issue4July/August 2020e13668 This article also appears in:Dermatologic Therapy COVID-19 Articles RelatedInformation

Topics & Concepts

MedicineApremilastCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyPsoriasisPsoriatic arthritisInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakPsoriasis: Treatment and PathogenesisDermatological and COVID-19 studiesCOVID-19 Clinical Research Studies
Apremilast as a potential treatment option for <scp>COVID</scp> ‐19: No symptoms of infection in a psoriatic patient | Litcius